Company and Stock Identity

How Gastroenterology Associates of New Jersey Connects to the Public Market

Company structure
Private physician group practice
Market access
No current public listing was verified.
Research focus
Two numbers in the public record disagree slightly, and the gap is instructive. The practice says 29 offices; the research announcement said 28 locations. Neither is wrong, they were counted at different times, and it is a small reminder to take a site count from the practice rather than from the partner announcing it. The bigger question for this group is whether research reaches patients. A partnership that begins with two research sites inside a 29 office practice is a pilot, however it is announced, so the thing to check is how many of those offices can actually offer a patient a trial a year later. Note also that the about page says nothing about clinical research, so the research arm is new enough that the practice has not yet written it into its own description.

The practice about page, read on 2026-11-14, says Gastroenterology Associates of New Jersey was founded in 2009 and describes itself as an integrated group practice with 49 gastroenterologists, 4 physician assistants and 8 nurse practitioners across 29 offices in Bergen, Essex, Passaic, Hudson, Morris and Ocean counties. The page does not name a parent company, an investor or a management services owner, and does not state whether the practice is physician owned, so this record claims no owner. Iterative Health announced the research partnership on 8 July 2026 and described the group as having 28 locations and more than 60 healthcare professionals, which is close to but not identical with the practice's own current figures. Checked on 2026-11-14.

Open the public company market data feed for the full directory, ownership relationships, stock identifiers, and dated snapshots.

First-Hand Company News

Latest Developments

... Iterative Health ... Company source

Iterative Health adds a 28 location New Jersey gut practice to its trial network

Iterative Health said on 8 July 2026 that it had become the research partner of Gastroenterology Associates of New Jersey, and that two research sites had been newly established at the practice in Toms River and Clifton, New Jersey. The announcement describes the group as having 28 locations and more than 60 healthcare professionals, says further sites across the network are under active discussion, and says the practice joins a global network of more than 110 Iterative Health sites. George Pavlou, chief executive of Gastroenterology Associates of New Jersey, is quoted saying the partnership gives the practice the infrastructure to offer patients access to the therapies that will define the next generation of treatment. Jonathan Ng, chief executive of Iterative Health, is quoted describing a deliberate strategy to create the most capable community based research network in the field. No financial terms are stated.

Why it matters: The reason this kind of deal keeps happening is arithmetic. Trials need patients, patients are mostly in community practices, and community practices have no way to run a study. Whoever solves that gets to sell sponsors something they genuinely cannot buy elsewhere, and the patient who gets offered a trial in Toms River instead of being told to drive to a city hospital is the real gain. Read the numbers carefully, though. Twenty eight locations is the practice; two is the number of research sites that now exist. Everything else is described as under discussion, which is not the same as signed. The 110 site network figure is also the company counting its own sites, with no way to tell how many are actively enrolling. The honest version of this story is that a large practice has started, not that a large practice has converted.

See company developments across the healthcare AI market.

Careers and Qualifications

What to Know Before Applying

Work areas: The practice runs its own career opportunities page, and its own description of the group points at two tracks: positions for gastroenterologists and positions for administrative staff. With 29 offices across six counties and a clinical team of about 61 people, the administrative and operational side is a substantial part of the organization rather than a small back office.

Qualification signal: A 29 office specialty group that has just taken on clinical research is hiring for coordination more than for novelty. The useful experience is running a service across many sites where each office has its own routine. For anyone near the new research sites in Toms River and Clifton, the signal is having enrolled patients inside a working clinic, because the trials sit alongside ordinary appointments rather than in a dedicated centre.

Check current roles at Gastroenterology Associates of New Jersey. A careers page is the source of record for openings. This profile does not claim a role is open unless the company lists it now.

Related Healthcare AI Roles

Training to Compare

Buyer Snapshot

Best-fit buyer
Trial sponsors, research site leaders, physician group executives weighing a research partnership, and investors reading a site network roll up
Primary use case
Host and staff clinical trials inside a community medical practice, and enrol patients who would otherwise never be offered a study
Typical deployment
Physician practice, specialty group, or research site operator. AI arrives through a sponsor or a research network partner rather than through a software purchase.

Evidence questions

  • How many of the named sites are actively enrolling patients right now, rather than contracted?
  • Who measured the enrolment result, the network or the sponsor paying for it?
  • Did patient volume survive the acquisition, or did the investigators leave with it?

Regulatory and workflow questions

  • Who holds the regulatory responsibility for the study at each site after an acquisition?
  • Which review board oversees the trials, and did it change when ownership changed?
  • How is informed consent handled when a practice becomes part of a research network?

Data and contract questions

  • Which patient data leave the practice, who receives them, and in what form?
  • Can the practice still see the study results it helped produce?
  • What happens to the research data if the network is sold again?

Evidence and Regulation

FDA Clearances on Record

No clearance is linked in this directory. That is not automatically a mark against the company. Some products support the people doing the work instead of reading a patient image or signal themselves.

First-Hand Sources